Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Cyclacel Pharmaceuticals Inc. (CYCC)

0.465   -0.014 (-3%) 08-22 15:26
Open: 0.470276 Pre. Close: 0.4794
High: 0.4703 Low: 0.4604
Volume: 29,777 Market Cap: 8M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.471 - 0.473 0.473 - 0.475
Low: 0.453 - 0.456 0.456 - 0.459
Close: 0.465 - 0.469 0.469 - 0.474

Technical analysis

as of: 2019-08-22 4:28:02 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 0.75     One year: 0.87
Support: Support1: 0.42    Support2: 0.28
Resistance: Resistance1: 0.64    Resistance2: 0.75
Pivot: 0.50
Moving Average: MA(5): 0.47     MA(20): 0.51
MA(100): 0.62     MA(250): 0.87
MACD: MACD(12,26): -0.03     Signal(9): -0.02
Stochastic oscillator: %K(14,3): 59.42     %D(3): 55.28
RSI: RSI(14): 39.40
52-week: High: 1.87  Low: 0.28  Change(%): -70.8
Average Vol(K): 3-Month: 11381  10-Days: 10485

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
CYCC has closed above bottom band by 28.2%. Bollinger Bands are 14.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 10 Apr 2019 19:06:00 Z
Cash Dividend On The Way From Cyclacel Pharmaceuticals Convertible Exchangeable Preferred Stock

Tue, 12 Dec 2017 18:48:23 Z
Health Care Sector Update for 12/12/2017: SLNO,GSK,EDIT,CYCC,DXTR

Wed, 19 Jul 2017 20:42:33 Z
Health Care Sector Update for 07/19/2017: VRTX,AEZS,CYCC

Wed, 19 Jul 2017 18:42:29 Z
Health Care Sector Update for 07/19/2017: EKSO,AEZS,CYCC

Wed, 19 Jul 2017 17:12:02 Z
Mid-Day Market Update: Crude Oil Up Over 1%; Cyclacel Pharma Shares Plummet

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 17.20
Shares Float (M) 13.66
% Held by Insiders 13.53
% Held by Institutions 2.95
Shares Short (K) 506
Shares Short P. Month (K)

Stock Financials

EPS -0.638
EPS Est. Current Year -2.250
EPS Est. Next Year -1.570
EPS Est. Next Quarter
Forward EPS 1.#IO
Book Value (p.s.) 1.400
PEG Ratio
Profit Margin
Operating Margin -6393.33
Return on Assets (ttm) -25.9
Return on Equity (ttm) -41.0
Qtrly Rev. Growth
Gross Profit (p.s.) -0.243
Sales Per Share
EBITDA (p.s.) -0.556
Qtrly Earnings Growth
Operating Cash Flow (M) -8.25
Levered Free Cash Flow (M) -6.60

Stock Valuations

P/E -0.73
P/E Growth Ratio -0.03
P/BV 0.33
P/S 799800000.00
P/CF -0.97

Dividends & Splits

Dividend Yield
Dividend Pay Date 2016-08-01
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2016-05-31
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.